Entering text into the input field will update the search result below

Rayno Life Sciences Stocks To Watch: ALR, CPHD, QDEL, RGDX

Dec. 03, 2012 6:58 PM ETCPHD, QDEL
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Rayno Life Sciences Tools and Diagnostics: Alere, Cepheid, Quidel and Response Genetics

All of these stocks are already on our focus list but lately have shown signs of strength.

Look for a firm bottom on Alere (ALR) at $18 and a move over $20.

Cepheid (CPHD) has been added as a new long term buy at $31.5.

Quidel has two news items and recent strength:

Jack Schuler has added positions to 15.3% and the Flu season has an early start.

Response Genetics (RGDX) has made a big move above base of $1.10:

Emerging Biomarker Diagnostics: BGMD,RGDX,VRML | Raygent.com

Disclosure: I am long ALR, CPHD, RGDX.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.